Toru Beppu - Concepedia

Author

Toru Beppu

Kumamoto University ORCID

Also Known As

Beppu T., Hiroaki Miyata, T BEPPU, T Beppu, T. BEPPU, T. Beppu, TORU BEPPU, Takahiro Beppu, Takanobu BEPPU, Toru BEPPU

610

Publications

16.9K

Citations

H-Index

174

Concepts

All Affiliations

Kumamoto University The University of Tokyo Kumamoto University Hospital Tokyo University of Agriculture

About

Toru Beppu is an author at Kumamoto University specializing in medicine, microbiology, and natural sciences.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	52	123	9.8K
2	Natural Sciences	30	34	5K
3	Biochemistry	29	37	4.6K
4	Health Sciences	19	27	1.4K
5	Engineering	15	17	936

Toru Beppu

240

Publications

15K

Citations

H-Index

Page 1

	Year	Citations
Potent and specific inhibition of mammalian histone deacetylase both in vivo and in vitro by trichostatin A. Minoru Yoshida, Masako Kijima, Motomu Akita, Journal of Biological Chemistry Histone ModificationsMolecular BiologyEpigeneticsTumor BiologyFriend Cell Differentiation	1990	1.9K
Trapoxin, an antitumor cyclic tetrapeptide, is an irreversible inhibitor of mammalian histone deacetylase. Masako Kijima, Minoru Yoshida, Kenji Sugita, Journal of Biological Chemistry Histone ModificationsAntitumor Cyclic TetrapeptideIrreversible InhibitorEpigeneticsTumor Biology	1993	510
Leptomycin B targets a regulatory cascade of crm1, a fission yeast nuclear protein, involved in control of higher order chromosome structure and gene expression. K. Nishi, Minoru Yoshida, Daisuke Fujiwara, Journal of Biological Chemistry Molecular RegulationGeneticsMolecular BiologyMolecular GeneticsDrug Resistance	1994	455
Glypican-3, overexpressed specifically in human hepatocellular carcinoma, is a novel tumor marker Tetsuya Nakatsura, Yoshihiro Yoshitake, Satoru Senju, Biochemical and Biophysical Research Communications OncologyHepatologyHuman Hepatocellular CarcinomaMedicineHistopathology	2003	428
Significance of alternatively activated macrophages in patients with intrahepatic cholangiocarcinoma Hasita Horlad, Yoshihiro Komohara, Hirohisa Okabe, Cancer Science T-regulatory CellImmunologyPathologyImmunologic MechanismCholangiopathies	2010	269
Long‐term and perioperative outcomes of laparoscopic versus open liver resection for hepatocellular carcinoma with propensity score matching: a multi‐institutional Japanese study Takeshi Takahara, Go Wakabayashi, Toru Beppu, Journal of Hepato-Biliary-Pancreatic Sciences	2015	258
A nomogram predicting disease‐free survival in patients with colorectal liver metastases treated with hepatic resection: multicenter data collection as a Project Study for Hepatic Surgery of the Japanese Society of Hepato‐Biliary‐Pancreatic Surgery Toru Beppu, Yoshihiro Sakamoto, Kiyoshi Hasegawa, Journal of Hepato-Biliary-Pancreatic Sciences	2011	219
CD44s Regulates the TGF-β–Mediated Mesenchymal Phenotype and Is Associated with Poor Prognosis in Patients with Hepatocellular Carcinoma Kosuke Mima, Hirohisa Okabe, Takatsugu Ishimoto, Cancer Research PathologyCancer BiologyTumor BiologyHepatobiliary TumorCancer Cell Biology	2012	219
Molecular Liver Cancer Prevention in Cirrhosis by Organ Transcriptome Analysis and Lysophosphatidic Acid Pathway Inhibition Shigeki Nakagawa, Lan Wei, Won Min Song, Cancer Cell LiverHepatologyLiver PhysiologyHepatitisPathology	2016	209
Induction of haem oxygenase-1 by nitric oxide and ischaemia in experimental solid tumours and implications for tumour growth Koichi Doi, Takaaki Akaike, Shin‐ichiro Fujii, British Journal of Cancer	1999	181

Page 1